Myocardial Strain Analysis in a Doxorubicin-Induced Cardiomyopathy Model

Ultrasound in Medicine and Biology

Volumn 34, Issue 3, 2008, Pages 370-378

  Piegari, Elena ^a   Di Salvo, Giovanni ^b   Castaldi, Biagio ^b   Vitelli, Maria Redenta ^a   Rodolico, Gabriella ^a   Golino, Paolo ^b   Calabrò, Raffaele ^a   Rossi, Francesco ^a   Berrino, Liberato ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b MONALDI HOSPITAL   (Italy)

Author keywords

Anthracyclines; Cardiomyopathy; Echocardiography; Strain rate imaging; Tissue Doppler

Indexed keywords

CARDIOLOGY; CELL MEMBRANES; ECHOCARDIOGRAPHY; PARAMETER ESTIMATION; RATS; STRAIN RATE;

ANTHRACYCLINES; CARDIOMYOPATHY; STRAIN RATE IMAGING;

BRAIN MODELS;

DOXORUBICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE; HISTOPATHOLOGY; IMAGING; NONHUMAN; PARAMETER; PRIORITY JOURNAL; RAT;

ANIMALS; ANTHRACYCLINES; DISEASE PROGRESSION; DOXORUBICIN; ECHOCARDIOGRAPHY, DOPPLER, COLOR; HYPERTROPHY, LEFT VENTRICULAR; MODELS, ANIMAL; MYOCARDIAL CONTRACTION; MYOCARDIUM; RATS; RATS, WISTAR; SIGNAL PROCESSING, COMPUTER-ASSISTED; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 43049145873     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2007.08.002     Document Type: Article

References (33)

1. Billingham M.E. Role of endomyocardial biopsy in diagnosis and treatment of heart disease. In: Silver M.D. (Ed). Cardiovascular Pathology (1991), Churchill Livingstone, New York, NY 1446-1486
2. Cittadini A., Fazio S., D'Ascia C., Basso A., Bazzicalupo L., Picardi G., and Sacca L. Subclinical cardiotoxicity by doxorubicin: A pulsed Doppler echocardiographic study. Eur Heart J 12 (1991) 1000-1005
3. D'Hooge J., Heimdal A., Jamal F., Kukulski T., Bijnens B., Rademakers F., Hatle L., Suetens P., and Sutherland G.R. Regional strain and SR measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiogr 1 (2000) 154-170
4. Di Salvo G., Drago M., Pacileo G., Rea A., Carrozza M., Santoro G., Bigazzi M.C., Caso P., Russo M.G., Carminati M., and Calabrò R. Comparison of strain rate imaging for quantitative evaluation of regional left and right ventricular function after surgical versus percutaneous closure of atrial septal defect. Am J Cardiol 96 (2005) 299-302
5. Ganame J., Claus P., Eyskens B., Uyttebroeck A., Renard M., D'hooge J., Gewillig M., Bijnens B., Sutherland G.R., and Mertens L. Acute cardiac functional and morphological changes after Anthracycline infusions in children. Am J Cardiol 99 (2007) 974-977
6. Goorin A.M., Chauvenet A.R., and Terez-Atayade A.R. Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer. J Pediatr 116 (1990) 144-147
7. Greenberg N.L., Firstenberg M.S., Castro P.L., Main M., Travaglini A., Odabashian J.A., Drinko J.K., Rodriguez L.L., Thomas J.D., and Garcia M.J. Doppler-derived myocardial systolic strain rate is a strong index of left ventricular contractility. Circulation 105 (2002) 99-105
8. Hatle L., and Sutherland G.R. Regional myocardial function a new approach. Eur Heart J 21 (2000) 1337-1357
9. Hirano T., Asanuma T., Azakami R., Okuda K., Ishikura F., and Beppu S. Noninvasive quantification of regional ventricular function in rats: assessment of serial change and spatial distribution using ultrasound strain analysis. J Am Soc Echocardiogr 18 (2005) 907-912
10. Jensen B.V., Skovsgaard T., and Nielsen S.L. Functional monitoring of anthracycline cardiotoxicity: A prospective blinded long-term observational study of outcome in 120 patients. Ann Oncol 13 (2002) 699-709
11. Koiwa Y., Kanai H., Hasegawa H., Saitoh Y., and Shirato K. Left ventricular transmural systolic function by high-sensitivity velocity measurement "phased-tracking method" across the septum in doxorubicin cardiomyopathy. Ultrasound Med Biol 28 (2002) 1395-1403
12. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J.S., Solomon S.D., Spencer K.T., Sutton M.S., Stewart W.J., Chamber Quantification Writing Group, American Society of Echocardiography's Guidelines and Standards Committee, and European Association of Echocardiography. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
13. Leitman M., Lysyansky P., Sidenko S., Shir V., Peleg E., Binenbaum M., Kaluski E., Krakover R., and Vered Z. Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr 17 (2004) 1021-1029
14. Lipshultz S.E., Colan S.D., Gelber R.D., Perez-Atayde A.R., Sallan S.E., and Sanders S.P. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324 (1991) 808-815
15. Matoba S., Hwang P.M., Nguyen T., and Shizukuda Y. Evaluation of pulsed Doppler tissue velocity imaging for assessing systolic function of murine global heart failure. J Am Soc Echocardiogr 18 (2005) 148-154
16. Matre K., Fannelop T., Dahle G.O., Heimdal A., and Grong K. Radial strain gradient across the normal myocardial wall in open-chest pigs measured with Doppler strain rate imaging. J Am Soc Echocardiogr 18 (2005) 1066-1073
17. Meinardi M.T., Van Veldhuisen D.J., Gietema J.A., Dolsma W.V., Boomsma F., van den Berg M.P., Volkers C., Haaksma J., de Vries E.G., Sleijfer D.T., and van der Graaf W.T. Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients. J Clin Oncol 19 (2001) 2746-2753
18. Marchandise B., Schroeder E., Bosly A., Doyen C., Weynants P., Kremer R., and Pouleur H. Early detection of doxorubicin cardiotoxicity: Interest of Doppler echocardiographic analysis of left ventricular filling dynamics. Am Heart J 118 (1989) 92-98
19. Minotti G., Menna P., Salvatorelli E., Cairo G., and Gianni L. Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56 (2004) 185-229
20. Mottram P.M., Leano R., and Marwick T.H. Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function. Am J Cardiol 92 (2003) 1434-1438
21. Neilan T.G., Jassal D.S., Perez-Sanz T.M., Raher M.J., Pradhan A.D., Buys E.S., Ichinose F., Bayne D.B., Halpern E.F., Weyman A.E., Derumeaux G., Bloch K.D., Picard M.H., and Scherrer-Crosbie M. Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur Heart J 27 (2006) 1868-1875
22. Rodrigues A.C., Hataishi R., Ichinose F., Bloch K.D., Derumeaux G., Picard M.H., and Scherrer-Crosbie M. Relationship of systolic dysfunction to area at risk and infarction size after ischemia-reperfusion in mice. J Am Soc Echocardiogr 17 (2004) 948-953
23. Rossi F., Filippelli W., Russo S., Filippelli A., and Berrino L. Cardiotoxicity of doxorubicin: Effects of drugs inhibiting the release of vasoactive substances. Pharmacol Toxicol 75 (1994) 99-107
24. Saha D.C., Saha A.C., Malik G., Astiz M.E., and Rackow E.C. Comparison of cardiovascular effects of tiletamine-zolazepam, pentobarbital, and ketamine-xylazine in male rats. J Am Assoc Lab Anim Sci 46 (2007) 74-80
25. Singal P.K., and Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 339 (1998) 900-905
26. Steinherz L.J., Steinherz P.G., Tan C.T., Heller G., and Murphy M.L. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 266 (1991) 1672-1677
27. Stoddard M.F., Seeger J., Liddell N.E., Hadley T.J., Sullivan D.M., Kupersmith J., et al. Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. J Am Coll Cardiol 20 (1992) 62-69
28. Sung R.Y., Huang G.Y., Shing M.K., Oppenheimer S.J., Li C.K., Li C.K., Lau J., and Yuen M.P. Echocardiographic evaluation of cardiac function in pediatric oncology patients treated with or without anthracyclines. Int J Cardiol 60 (1997) 239-248
29. Sutherland G.R., Di Salvo G., Claus P., D'Hooge J., and Bijnens B. Strain and strain rate imaging: A new clinical approach to quantifying regional myocardial function. J Am Soc Echocardiogr 17 (2004) 788-802
30. Urheim S., Edvardsen T., Torp H., Angelsen B., and Smiseth O.A. Myocardial strain by Doppler echocardiography validation of a new method to quantify regional myocardial function. Circulation 102 (2000) 1158-1164
31. Weytjens C., Cosyns B., D'hooge J., Gallez C., Droogmans S., Lahoute T., Franken P., and Van Camp G. Doppler myocardial imaging in adult male rats: Reference values and reproducibility of velocity and deformation parameters. Eur J Echocardiogr 7 (2006) 411-417
32. Wong C.Y., O'Moore-Sullivan T., Leano R., Byrne N., Beller E., and Marwick T.H. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 110 (2004) 3081-3087
33. Yinbo L., Garson C., Epstein F.H., French B.A., and Hossack J.A. High resolution 2D quantification of myocardial motion abnormalities in mice using high resolution ultrasound with MRI validation. Biomedical Imaging: Macro to Nano, 2006 (2006) 630-633 3rd IEEE International Symposium, April 6-9